Genus plc ( (GB:GNS) ) just unveiled an announcement.
Genus plc reported a strong financial performance for the first half of the fiscal year, with a 19% increase in adjusted operating profit and a 21% rise in adjusted profit before tax. The company achieved significant cash generation and maintained its interim dividend. Strategic progress was noted in the porcine sector with new customer wins in China and advancements in gene editing technology, while the bovine sector saw improvements through the Value Acceleration Programme. Genus expects continued growth, although geopolitical and currency challenges remain.
More about Genus plc
Genus plc is a biotechnology company that specializes in animal breeding and genetic improvement, primarily serving the dairy, beef, and pork food production sectors. The company operates globally, selling products such as semen, embryos, and breeding animals with superior genetics under the trademarks ‘ABS’ for cattle and ‘PIC’ for pigs. Genus is headquartered in Basingstoke, UK, with operations in over 24 countries and research labs in Madison, Wisconsin, USA.
YTD Price Performance: 15.23%
Average Trading Volume: 129,101
Technical Sentiment Consensus Rating: Buy
Current Market Cap: £1.17B
Find detailed analytics on GNS stock on TipRanks’ Stock Analysis page.